The blood-brain barrier: bottleneck in brain drug development.
The blood-brain barrier (BBB) is formed by the brain capillary endothelium and excludes from the brain approximately 100% of large-molecule neurotherapeutics and more than 98% of all small-molecule drugs. Despite the importance of the BBB to the neurotherapeutics mission, the BBB receives insufficient attention in either academic neuroscience or industry programs. The combination of so little effort in developing solutions to the BBB problem, and the minimal BBB transport of the majority of all potential CNS drugs, leads predictably to the present situation in neurotherapeutics, which is that there are few effective treatments for the majority of CNS disorders. This situation can be reversed by an accelerated effort to develop a knowledge base in the fundamental transport properties of the BBB, and the molecular and cellular biology of the brain capillary endothelium. This provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.
Pardridge
William M
WM
Department of Medicine, UCLA, Los Angeles, California 90024, USA. wpardridge@mednet.ucla.edu
D000281:Administration, Intranasal; D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000502:physiology*; D002352:Carrier Proteins / Q000378:metabolism; D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology*; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D006860:Hydrogen Bonding; D008970:Molecular Weight
D002352:Carrier Proteins; D002491:Central Nervous System Agents
Drug Discov Today. 2002 Jan 1;7(1):5-7
11790589
Acta Neuropathol. 1988;77(1):5-13
3149121
Ann Neurol. 2003 Oct;54(4):479-87
14520660
J Neurochem. 1990 Jun;54(6):1882-8
2338547
Brain Res. 2001 Jan 19;889(1-2):49-56
11166685
Cancer Res. 1999 Dec 15;59(24):6159-63
10626807
Stroke. 2001 Jun;32(6):1378-84
11387502
Clin Cancer Res. 2004 Jun 1;10(11):3667-77
15173073
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14164-9
8943078
J Neurochem. 2001 Feb;76(4):1032-41
11181822
Exp Neurol. 1994 May;127(1):23-36
8200435
J Pharm Sci. 2003 Aug;92(8):1531-44
12884241
Cancer Drug Deliv. 1984 Summer;1(3):207-11
6399858
Curr Biol. 1998 Jul 30-Aug 13;8(16):923-6
9707404
J Nucl Med. 2004 Oct;45(10):1766-75
15471847
Hum Gene Ther. 2004 Apr;15(4):339-50
15053859
Exp Neurol. 1997 Apr;144(2):381-99
9168838
Neurology. 2003 May 27;60(10):1669-71
12771261
J Clin Invest. 1979 Jul;64(1):145-54
447850
Adv Anat Embryol Cell Biol. 1980;59:I-VI,1-62
6996438
Scand J Infect Dis Suppl. 2003;106:41-4
15000582
Brain Pathol. 2003 Jan;13(1):104-10
12580550
J Membr Biol. 1998 Oct 1;165(3):201-11
9767674
Science. 1970 Dec 11;170(3963):1212-3
5478194
Science. 1982 Jul 9;217(4555):164-6
7089551
J Membr Biol. 1986;92(2):111-9
3761357
J Neurosurg. 1996 Dec;85(6):1056-65
8929495
J Neurochem. 1978 Feb;30(2):299-308
624938
Pharm Res. 1996 May;13(5):671-82
8860421
Brain Res. 1998 May 4;792(1):10-5
9593802
J Nucl Med. 2002 Jul;43(7):948-56
12097468
Exp Brain Res. 1997 Jul;115(3):546-51
9262210
J Neuroimmunol. 2001 Mar 1;114(1-2):168-72
11240028
J Neurochem. 2001 Mar;76(5):1597-600
11238745
J Membr Biol. 1971 Dec;4(1):193-208
24174239
J Neurochem. 2002 Apr;81(1):203-6
12067234
Cancer Res. 1992 Jan 1;52(1):138-43
1727374
Eur J Pharmacol. 1972 Apr;18(1):79-82
5031276
Brain Res. 1991 Jun 7;550(2):257-62
1715805
J Gene Med. 2003 Dec;5(12):1039-45
14661179
Radiology. 2001 Sep;220(3):640-6
11526261
Acta Neuropathol. 1971;19(2):145-54
5126829
J Comb Chem. 1999 Jan;1(1):55-68
10746014
Mol Ther. 2002 Jul;6(1):67-72
12095305
Biochim Biophys Acta. 1975 Mar 25;382(3):377-92
1125240
J Clin Invest. 1961 Nov;40:1997-2006
13879330
J Comp Neurol. 2003 Jun 23;461(2):250-61
12724841
Pharm Res. 2002 Aug;19(8):1137-43
12240939
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12754-9
11592987
Neurosci Lett. 1995 May 12;190(3):203-6
7637893
J Pharmacol Exp Ther. 2002 May;301(2):605-10
11961063
Mol Ther. 2003 Jan;7(1):11-8
12573613
Brain Res. 1995 Sep 18;692(1-2):278-82
8548316
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12079-84
10518579
Nature. 1999 Jul 8;400(6740):173-7
10408445
Brain Res. 1995 May 22;680(1-2):196-206
7663977
Arch Virol. 1981;68(1):19-25
6166278
Brain Res. 1995 Jun 19;683(2):164-71
7552351
Nat Neurosci. 2002 Jun;5(6):514-6
11992114
Fed Proc. 1984 Feb;43(2):214-9
6692941
J Pharmacol Exp Ther. 1975 Oct;195(1):73-83
810575
J Cereb Blood Flow Metab. 2001 Aug;21(8):929-36
11487728
J Pharmacol Exp Ther. 1996 Oct;279(1):77-83
8858978
J Neurosci Nurs. 1998 Apr;30(2):81-90
9642616
Cancer Chemother Pharmacol. 1985;14(3):238-42
3995684
Vascul Pharmacol. 2002 Jun;38(6):355-64
12529930
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1426-30
7877995
Biochim Biophys Acta. 1975 Jun 25;394(2):211-9
1138930
J Neurocytol. 1995 Oct;24(10):795-806
8586999
J Cereb Blood Flow Metab. 2002 Feb;22(2):223-31
11823720
Brain Res. 1999 Jun 19;832(1-2):84-96
10375654
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):254-9
9874805
J Neurol Sci. 2003 Dec 15;216(1):113-8
14607312
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
11274893
Am J Physiol. 1994 Dec;267(6 Pt 2):H2229-36
7810722
Neuroscience. 1998 Oct;86(4):1245-57
9697130
J Pharmacol Exp Ther. 1994 Jan;268(1):14-8
8301550